台北榮民總醫院外科部

:::

呂信邦 (Hsin-Bang Leu)

複診掛號初診掛號

Tsai TY, Hsu PF, Wu CH, Huang SS, Chan WL, Lin SJ, Chen JW, Lu TM, Leu HB. Association between Coronary Artery Plaque Progression and Liver Fibrosis Biomarkers in Population with Low Calcium Scores. Nutrients. 2022;14(15):3163.
Tsai TY, Hsu PF, Wu CH, Yang YL, Chen SC, Huang SS, Chan WL,Lin SJ, Chen JW, Pan JP, Charng MJ, Chen YH, Wu TC, Lu TM, Huang PH, Cheng HM, Huang CC, Sung SH, Lin YJ, Leu HB. Association between phosphate and long-term outcome in CAD patients underwent coronary intervention. Sci Rep. 2021;11(1):20080.
Yang YL, Chen SC, Wu CH, Huang SS, Chan WL, Lin SJ, Chou CY, Chen JW, Ju-Pin P, Charng MJ, Chen YH, Wu TC, Lu TM, Hsu PF, Huang PH, Cheng HM, Huang CC, Sung SH, Lin YJ, Leu HB. Optimal blood pressure for patients with end-stage renal disease following coronary interventions. J Clin Hypertens (Greenwich). 2021; (8):1622-1630.
Hsu PF, Wang YW, Lin CC, Wang YJ, Ding YZ, Liou TL, Huang SS, Lu TM, Chan WL, Lin SJ, Leu HB. The association of the steatosis severity in fatty liver disease with coronary plaque pattern in general population. Liver Int. 2021;41(1):81-90.
Lim SS, Yang YL, Chen SC, Wu CH, Huang SS, Chan WL, Lin SJ, Chen JW, Chou CY, Pan JP, Charng MJ, Chen YH, Wu TC, Lu TM, Hsu PF, Huang PH, Cheng HM, Huang CC, Sung SH, Lin YJ, Leu HB. Association of variability in uric acid and future clinical outcomes of patient with coronary artery disease undergoing percutaneous coronary intervention. Atherosclerosis. 2020 ;297:40-46.

限於篇幅,以上謹為代表著作